Recruiting
MBSR and NLP, Postpartum Breastfeeding and Depression
The postnatal period is a risky period in which mothers experience regressive and progressive changes and rapid biopsychosocial changes. Since this process affects not only the mother but also the family, mothers are under intense stress due to adaptation to the changes that occur in this period.
ClinicalTrials.gov IDNCT06628986
PhaseNA
Enrollment90
SponsorAysegul Kilicli
Age19 Years
SexFEMALE
Conditions studied
Breastfeeding, Exclusive, Fatigue, Sleep, Postpartum Depression
About this study
The postnatal period is a risky period in which mothers experience regressive and progressive changes and rapid biopsychosocial changes. Since this process affects not only the mother but also the family, mothers are under intense stress due to adaptation to the changes that occur in this period.
Interventions
- Behavioral: MBSR — 20 minutes once a week for 8 weeks
- Behavioral: NLP — NLP Neurolinguistic programming, 20 minutes once a week for 8 weeks
- Behavioral: control — control group, no practice,
Primary outcomes
- Visual Analogue Scale for Fatigue (VAS-F) (before the first application)
- Visual Analogue Scale for Fatigue (VAS-F) (Week 4)
- Visual Analogue Scale for Fatigue (VAS-F) (Week 8)
- Pittsburgh Sleep Quality Index (PSQI) (before the first application)
- Pittsburgh Sleep Quality Index (PSQI) (week 4)
- Pittsburgh Sleep Quality Index (PSQI) (week 8)
- Bristol Breastfeeding Assessment Tool (BBAT) (before the first application)
- Bristol Breastfeeding Assessment Tool (BBAT) (week 4)
Eligibility information
Inclusion Criteria:
* 19-35 years old
* caesarean section
* primiparous
* breastfeeding women
Exclusion Criteria:
* women who refused to participate in the research.
Study locations
- Şanlıurfa training and research hospital, Sanliurfa, Eyalet/Yerleşke 63000 Turkey (Türkiye)
Before you participate: Varda Clinical is an independent discovery tool, not the study sponsor or a medical provider. Eligibility can only be determined by the official study team. Discuss potential risks and benefits with a qualified healthcare professional.
Source: ClinicalTrials.gov. Record last refreshed by Varda Clinical: 2026-09-27.